{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:06:39Z","timestamp":1784804799468,"version":"3.55.0"},"reference-count":16,"publisher":"Japanese Society for the Study of Xenobiotics","issue":"4","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2014]]},"DOI":"10.2133\/dmpk.dmpk-13-sh-138","type":"journal-article","created":{"date-parts":[[2014,2,10]],"date-time":"2014-02-10T23:01:28Z","timestamp":1392073288000},"page":"352-355","source":"Crossref","is-referenced-by-count":20,"title":["Quinine Compared to 4\u03b2-Hydroxycholesterol and Midazolam as Markers for CYP3A Induction by Rifampicin"],"prefix":"10.2133","volume":"29","author":[{"given":"Linda","family":"Bj\u00f6rkhem-Bergman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"B\u00e4ckstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Nyl\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"R\u00f6nquist-Nii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Bredberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy B.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Bertilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Diczfalusy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"900","reference":[{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1528-1157.1996.tb00021.x","article-title":"Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin","volume":"37","author":"Backman","year":"1996","journal-title":"Epilepsia"},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.qai.0000167156.44980.33","article-title":"Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study","volume":"39","author":"Gerber","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11481-006-9034-2","article-title":"MDR- and CYP3A4-mediated drug-drug interactions","volume":"1","author":"Pal","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0020","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1124\/dmd.113.052316","article-title":"Comparison of endogenous 4\u03b2-hydroxycholesterol with midazolam as markers for CYP3A4 induction by rifampicin","volume":"41","author":"Bj\u00f6rkhem-Bergman","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00228-003-0575-5","article-title":"Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man","volume":"59","author":"Mirghani","year":"2003","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00228-006-0159-2","article-title":"Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers","volume":"62","author":"Krupka","year":"2006","journal-title":"Eur J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/009127002401382614","article-title":"Single plasma concentrations of 1\u2032-hydroxymidazolam or the ratio of 1\u2032-hydroxymidazolam: midazolam do not predict midazolam clearance in healthy subjects","volume":"42","author":"Rogers","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/FPC.0b013e3282f50ee9","article-title":"4\u03b2-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians","volume":"18","author":"Diczfalusy","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0045","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.fpc.0000230411.89973.1b","article-title":"CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population","volume":"16","author":"Mirghani","year":"2006","journal-title":"Pharmacogenet. Genomics"},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2125.2008.03309.x","article-title":"4\u03b2-hydroxycholesterol as an endogenous marker for CYP3A4\/5 activity. Stability and half-life of elimination after induction with rifampicin","volume":"67","author":"Diczfalusy","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0055","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/clpt.2013.128","article-title":"Evaluation of endogenous metabolic markers of hepatic CYP3A activity using metabolic profiling and midazolam clearance","volume":"94","author":"Shin","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5414\/CP201831","article-title":"Genotype-phenotype variability in human CYP3A locus in Nepalese people residing in Bangladesh","volume":"51","author":"Hassan","year":"2013","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0065","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00228-007-0365-6","article-title":"Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedation","volume":"63","author":"Fromm","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0070","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.clpt.6100237","article-title":"Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam","volume":"82","author":"Kharasch","year":"2007","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/tpj.2009.21","article-title":"Association of genotypes of the CYP3A cluster with midazolam disposition in vivo","volume":"9","author":"Miao","year":"2009","journal-title":"Pharmacogenomics J."},{"key":"10.2133\/dmpk.DMPK-13-SH-138_bb0080","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00228-008-0503-9","article-title":"No role for the CYP3A5*3 polymorphism in intestinal and hepatic metabolism of midazolam","volume":"64","author":"Tomalik-Scharte","year":"2008","journal-title":"Eur J. Clin. Pharmacol."}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715303487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1347436715303487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T07:38:21Z","timestamp":1498117101000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436715303487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"alternative-id":["S1347436715303487"],"URL":"https:\/\/doi.org\/10.2133\/dmpk.dmpk-13-sh-138","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}